Notice to Physicians:
If you are a physician with specific questions that are not answered by one of these articles then EMAIL me.

 

Get all the product labeling  information by clicking this link  Secretropin.

The Millennium Health Centers, Inc is committed to a long term, Prospective Clinical Study on the efficacy and benefits from Secretropin. In lieu of subjective testing used by the majority of other secretagogue products, The Millennium continues to obtain objective results through continued laboratory testing.  In so doing, we have found that 8% of the patient population did not respond to the product. In that group of non-responders, we believe that they are Somatostatin sensitive individuals, those that appear to produce naturally high levels of Somatostatin. The addition of supplemental nocturnal L-Arginine, has helped them to respond to Secretropin.  

2011: A two year composite study of Secretropin's efficacy in raising endogenous Growth Hormone production in Adult Humans,
Ms. Susan Dollinger of University Compounding Pharmacy has been working with a large number of physicians who have voluntarily selected Secretropin Rx as the first choice approach to growth hormone enhancement treatment for their patients. After almost 4 years the consensus has been overwhelmingly positive on the ability of Secretropin Rx to raise baseline IGF-1 and BP-3 levels by between 50% and 300%. The testimonials that have been shared with us have precipitated the project of collecting the raw data from over 70 physicians with a total patient count of 100.  The use and benefits of Secretropin have been documents in two previous studies but, we feel that this more independent study (with results coming from outside physicians) will offer further unbiased results.  In the end, you will be the ultimate judge of the product.
Expected in the 3rd or 4th quarter of 2011.   

2010: Preservation of Endogenous Growth Hormone Production Using a Combined rhGH-Secretagogue Protocol; The GH-SRx Protocol.  Interventional Endocrinology Protocols, Gordon, ML,, Crisler, J., Anand S., Chiapuzio,C.  July 17, 2009.

2009: Secretropin - A Nanoliposomal Delivered Secretagogue finishes a second year of clinical evaluation. Journal of Anti Aging Protocology, Vol. 4, No. 1, January 2009. Gordon, ML. Gordon, EF, Gordon, AM. March 17, 2009